This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mojo Organics, Inc. Appoints J.R. LeShufy To The Company's Board Of Directors

NEW YORK, Feb. 2, 2012 /PRNewswire/ -- Mojo Organics, Inc. (OTCBB: MOJO) ("Mojo" or the "Company") today announced the appointment of J. Robert ("J.R.") LeShufy to the company's Board of Directors. LeShufy is a founding investor in Mojo and brings a diverse business background to the Company. He has been an entrepreneur in a wide range of ventures from the oil industry, construction, and dredging. He is currently a senior advisor to The Broadsmoore Group, a privately held investment advisory and merchant banking firm.

"We are pleased to welcome J.R. to Mojo's board. His significant experience in launching companies both here and abroad will be instrumental in guiding the company's growth," said Glenn Simpson, CEO of Mojo. "We look forward to J.R.'s leadership as we continue developing consumer products."

In the 1990's, LeShufy formed the second approved joint venture in the former Soviet Union in the Siberian oil fields of the Komi Region with his partner Samson Drilling of Oklahoma. He also worked with Brown and Root, a division of Halliburton, to help the company access the oil fields in Kazakhstan.

After a meeting with the Komarov Institute in St. Petersburg, the world's oldest botanical gardens started by Peter the Great, LeShufy formed a joint venture known as Panax Pharmaceuticals. During that time, he worked with the Institute of Traditional Medicine in Guang-Xi, China, to incorporate Chinese botanical products for Western medicine. Back in the U.S., he took Panax public. The company subsequently changed its name to Inkine Pharmaceutical and was sold to Salix Pharmaceutical for $200 million.

In 2004, LeShufy was a founder of Glyconix Corp., a company specializing in sugar chemistry to improve the efficacy of small molecule drugs. Prior to that, he was on the board of IMT Inc., a company whose mission was to evaluate covert Navy projects. LeShufy was granted top level security in this capacity. He volunteered and served in the U.S. Army Air Corps.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.01 -2.70%
FB $104.02 -5.90%
GOOG $684.00 -3.40%
TSLA $163.01 -7.00%
YHOO $27.97 -4.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs